Caplight Directory>Companies>Topos Bio-preview>Toposbio


Topos Bio

Topos Bio

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://toposbio.ai

Last Round

Seed

Jan 8, 2026

Total Funding Raised

$10.5M

Company Overview

Topos Bio is an AI-powered biotechnology company developing therapies for intrinsically disordered proteins (IDPs) involved in diseases like neurodegeneration and oncology.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

intrinsically disordered proteinsIDPsundruggable targetsAI drug discoverydrug discovery platformbiotech AIgenerative biologyfoundation modelprotein dynamics modelingrational drug designsmall molecule therapeuticsin silico drug discoveryneurodegeneration therapyoncology drug discoverywet lab validation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Topos Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Topos Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedJan 8, 2026
View all Funding Rounds

Topos Bio Investors

Notable investors and investment history

InvestorRounds
Boldstart VenturesSeed
NeoSeed
Threshold VenturesSeed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 8, 2026

    $11M raised in Seed round.

View all signals

Topos Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Topos Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Topos Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Year Founded2024
Last FundingJan 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.